Rapid microbiology testing is a method of detecting the presence of microorganisms in a sample in a shorter time frame than traditional microbiology testing methods. This type of testing has become increasingly important in industries such as food and beverage, pharmaceuticals, and healthcare, where rapid identification of pathogens can be critical. The global rapid microbiology testing market is expected to increase by USD 3.3 billion, at a compound annual growth rate (CAGR) of 8.62% from 2023 to 2029, according to the latest edition of the Global Rapid Microbiology Testing Market Report.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, method, application, and region. The global market data on rapid microbiology testing can be segmented by product: consumables, instruments, reagents & kits. The instruments segment is estimated to account for the largest share of the global rapid microbiology testing market. Rapid microbiology testing market is further segmented by method: cellular component-based, growth-based, nucleic acid-based, viability-based, others. The growth-based segment held the largest revenue share in 2022. Based on application, the rapid microbiology testing market is segmented into: clinical diagnosis, cosmetics and personal care, environmental, food and beverages, pharmaceuticals and biologics, research, others. Globally, the clinical segment made up the largest share of the rapid microbiology testing market. On the basis of region, the rapid microbiology testing market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global rapid microbiology testing market in 2022.

The instruments market is further segmented into automated ID and AST systems, mass spectrometers, PCR systems, cytometers, active air samplers, bioluminescence- and fluorescence-based detection systems, others. The automated ID and AST systems segment held the largest share of the global rapid microbiology testing market in 2022 and is anticipated to hold its share during the forecast period. Furthermore, the reagents & kits market has been categorized into sterility testing reagents & kits, others. In 2022, the sterility testing reagents & kits segment made up the largest share of revenue generated by the rapid microbiology testing market.

The global rapid microbiology testing market is highly competitive. As of 2022, the major players in the global rapid microbiology testing market were Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA , Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Don Whitley Scientific Limited, Merck KGaA, Neogen Corporation, Quidel Corporation, Rapid Micro Biosystems Inc., Sartorius Group AG, Thermo Fisher Scientific Inc., TSI Incorporated.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
• Get a detailed picture of the Global Rapid Microbiology Testing Market
• Identify segments/areas to invest in over the forecast period in the Global Rapid Microbiology Testing Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.